Mehran Gholamin
- Immunology top 10%
- Immunotherapy and Immune Responses 8
- Cancer Research top 10%
- Oncology top 10%
- Cancer Cells and Metastasis 11
-
- RNA Interference and Gene Delivery 7
- Glycosylation and Glycoproteins Research 5
- Cancer-related gene regulation 4
-
- Esophageal Cancer Research and Treatment 6
-
- Asthma and respiratory diseases 5
-
- Gastric Cancer Management and Outcomes 3
- Co-authors
- Mohammad Reza AbbaszadeganBahram MemarVahid BagheriAmirhossein SahebkarAmir Abbas MomtaziMoein FarshchianMohammad Mahdi ForghanifardOmeed Moaven
- Cited by
- ImmunologyCancer ResearchOncology
- Journals
- SHILAP Revista de lepidopterología (4 papers)PLoS ONE (1 paper)Journal of Clinical Microbiology (1 paper)
- Partner nations
- IranUnited StatesUnited Kingdom
In The Last Decade
Mehran Gholamin
52 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 99
- Immunology 263
- Cancer Research 185
- Oncology 333
- Molecular Biology 482
- Immunology and Allergy 31
Countries citing papers authored by Mehran Gholamin
This map shows the geographic impact of Mehran Gholamin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehran Gholamin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehran Gholamin more than expected).
Fields of papers citing papers by Mehran Gholamin
This network shows the impact of papers produced by Mehran Gholamin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehran Gholamin. The network helps show where Mehran Gholamin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mehran Gholamin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2022 | 0 | |
| 5 | 2021 | 23 | |
| 6 | 2021 | 19 | |
| 7 | 2020 | 7 | |
| 8 | 2019 | 21 | |
| 9 | 2018 | 16 | |
| 10 | Biological and Clinicopathological Significance of Cripto-1 Expression in the Progression of Human ESCC | 2017 | 0 |
| 11 | 2017 | 38 | |
| 12 | 2016 | 159 | |
| 13 | Effects of oxidative stress on modulating unfolded protein response signalingpathway in K562 chronic myeloid cell line. | 2016 | 1 |
| 14 | 2016 | 25 | |
| 15 | 2015 | 11 | |
| 16 | 2014 | 16 | |
| 17 | HIGHLY EFFICIENT TRANSFECTION OF DENDRITIC CELLS DERIVED FROM ESOPHAGEAL SQUAMOUS CELL CARCINOMA PATIENT: OPTIMIZATION WITH GREEN FLUORESCENT PROTEIN AND VALIDATION WITH TUMOR RNA AS A TOOL FOR IMMUNO-GENETHERAPY | 2010 | 2 |
| 18 | 2010 | 23 | |
| 19 | 2010 | 28 | |
| 20 | 2005 | 17 |
About Mehran Gholamin
Mehran Gholamin is a scholar working on Oncology, Immunology and Cancer Research, having authored 58 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (11 papers), Immunotherapy and Immune Responses (8 papers), RNA Interference and Gene Delivery (7 papers), Esophageal Cancer Research and Treatment (6 papers), Glycosylation and Glycoproteins Research (5 papers), Asthma and respiratory diseases (5 papers), Cancer-related gene regulation (4 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Immunology (263 citations), Cancer Research (185 citations) and Oncology (333 citations). Mehran Gholamin has collaborated with scholars based in Iran, United States and United Kingdom. Frequent co-authors include Mohammad Reza Abbaszadegan, Bahram Memar, Vahid Bagheri, Amirhossein Sahebkar, Amir Abbas Momtazi, Moein Farshchian, Mohammad Mahdi Forghanifard, Omeed Moaven, Meysam Moghbeli and Jamshidkhan Chamani. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.